Garland Capital Management Inc buys $3,608,488 stake in Monsanto Company (MON)

Monsanto Company (MON) : Garland Capital Management Inc scooped up 50 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 18, 2016. The investment management firm now holds a total of 33,800 shares of Monsanto Company which is valued at $3,608,488.Monsanto Company makes up approximately 2.78% of Garland Capital Management Inc’s portfolio.

Other Hedge Funds, Including , Carroll Financial Associates reduced its stake in MON by selling 300 shares or 6.88% in the most recent quarter. The Hedge Fund company now holds 4,058 shares of MON which is valued at $433,232. Monsanto Company makes up approx 0.07% of Carroll Financial Associates’s portfolio. Eqis Capital Management sold out all of its stake in MON during the most recent quarter. The investment firm sold 2,688 shares of MON which is valued $286,111. Douglass Winthrop Advisors added MON to its portfolio by purchasing 2,701 company shares during the most recent quarter which is valued at $273,152. Monsanto Company makes up approx 0.02% of Douglass Winthrop Advisors’s portfolio.Atria Investments reduced its stake in MON by selling 77 shares or 1.78% in the most recent quarter. The Hedge Fund company now holds 4,247 shares of MON which is valued at $429,499. Monsanto Company makes up approx 0.05% of Atria Investments’s portfolio. Central Bank Trust Co sold out all of its stake in MON during the most recent quarter. The investment firm sold 114 shares of MON which is valued $11,529.

Monsanto Company closed down -0.11 points or -0.10% at $106.76 with 27,11,013 shares getting traded on Wednesday. Post opening the session at $106.94, the shares hit an intraday low of $106.7 and an intraday high of $107.64 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.